Module 6: Genetic Toxicology

Recorded On: 08/05/2021

image
image


This module will provide an overview of genetic toxicology with a focus on the ICH S2(R1) guideline. Genetic toxicology testing is conducted to assess the ability of drugs to induce gene mutations as well as chromosomal damage (i.e., clastogenicity and aneugenicity). A battery of tests is used to evaluate these endpoints with the goal of predicting human carcinogenic potential. The presentation will cover both in vitro and in vivo genetic toxicology tests with specific discussion of principles and mechanisms, study design, and data interpretation. Decision-making, including discussion of follow-up strategies to mitigate concern with positive results, will be reviewed. In addition, differences in genetic toxicology testing strategies for small-molecule drugs, non-small-molecule drugs, and impurities will be described. Finally, key points will be highlighted through the use of case studies.

Mark Powley, PhD

Mark Powley, PhD

Distinguished Research Scientist

Merck & Co., Inc.

Dr. Mark Powley received a PhD in toxicology from Purdue University and completed postdoctoral training at the University of North Carolina – Chapel Hill. From 2004 to 2009 he worked in the general toxicology, biochemical toxicology, and genetic toxicology groups at Merck & Co. In 2009 he moved to the US FDA Center for Drug Evaluation and Research (CDER), Office of New Drugs. In addition to reviewing nonclinical data, Dr. Powley co-chaired CDER pharmacology/toxicology subcommittees focused on genetic toxicology as well as computational toxicology. He was a member of the Genetic Toxicology Association Board of Directors from 2009–2012, serving as chair in 2011–2012. Dr. Powley rejoined Merck & Co. in 2017 and is currently a Distinguished Research Scientist within the Nonclinical Drug Safety organization. His primary role involves supporting mutagenic and non-mutagenic impurity safety assessment efforts.

Key:

Complete
Failed
Available
Locked
Module 6: Genetic Toxicology
Module 6: Genetic Toxicology, Mark Powley, PhD
Recorded 08/05/2021  |  90 minutes
Recorded 08/05/2021  |  90 minutes As part of your registration, you will have unlimited access to the module recording for 30 days. Your 30-day access period begins when you first access the recording. Once the access period begins, it cannot be reset or restarted. To receive a certificate of completion, you must watch the recording for the minimum required viewing time. Please keep the recording open while viewing, as the system tracks your viewing time during the active session. If you close your browser before meeting the minimum viewing requirement, your viewing progress may not be retained. Once you have met the viewing requirement, the module survey will become available. After completing the survey, you will be able to access and download your certificate of completion. If you have any questions, please contact ACT Headquarters at [email protected].
Survey
13 Questions
13 Questions ACT values your feedback. Please help us continue to provide high-quality educational offerings by completing this short survey. The survey will become available after you have met the minimum viewing requirement for the recording. Once you complete the survey, your certificate of completion will become available on your dashboard or for download.
Certificate
No credits available  |  Certificate available
No credits available  |  Certificate available Your certificate of completion will become available after you have met the minimum viewing requirement and completed the module survey.